139 related articles for article (PubMed ID: 15816863)
1. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Petri S; Choi DK; Chen J; Calingasan NY; Beal MF
J Neurochem; 2005 Apr; 93(2):403-11. PubMed ID: 15816863
[TBL] [Abstract][Full Text] [Related]
2. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
3. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.
Pompl PN; Ho L; Bianchi M; McManus T; Qin W; Pasinetti GM
FASEB J; 2003 Apr; 17(6):725-7. PubMed ID: 12586733
[TBL] [Abstract][Full Text] [Related]
4. Increased expression and activation of cytosolic phospholipase A2 in the spinal cord of patients with sporadic amyotrophic lateral sclerosis.
Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Kobayashi M
Acta Neuropathol; 2010 Mar; 119(3):345-54. PubMed ID: 20066429
[TBL] [Abstract][Full Text] [Related]
5. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.
Almer G; Guégan C; Teismann P; Naini A; Rosoklija G; Hays AP; Chen C; Przedborski S
Ann Neurol; 2001 Feb; 49(2):176-85. PubMed ID: 11220737
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
[TBL] [Abstract][Full Text] [Related]
9. Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS.
Azari MF; Profyris C; Le Grande MR; Lopes EC; Hirst J; Petratos S; Cheema SS
Eur J Neurol; 2005 May; 12(5):357-64. PubMed ID: 15804265
[TBL] [Abstract][Full Text] [Related]
10. Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis.
Okuno T; Nakatsuji Y; Kumanogoh A; Koguchi K; Moriya M; Fujimura H; Kikutani H; Sakoda S
J Neurochem; 2004 Oct; 91(2):404-12. PubMed ID: 15447673
[TBL] [Abstract][Full Text] [Related]
11. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
12. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
Butovsky O; Jedrychowski MP; Cialic R; Krasemann S; Murugaiyan G; Fanek Z; Greco DJ; Wu PM; Doykan CE; Kiner O; Lawson RJ; Frosch MP; Pochet N; Fatimy RE; Krichevsky AM; Gygi SP; Lassmann H; Berry J; Cudkowicz ME; Weiner HL
Ann Neurol; 2015 Jan; 77(1):75-99. PubMed ID: 25381879
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
14. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.
Yiangou Y; Facer P; Durrenberger P; Chessell IP; Naylor A; Bountra C; Banati RR; Anand P
BMC Neurol; 2006 Mar; 6():12. PubMed ID: 16512913
[TBL] [Abstract][Full Text] [Related]
15. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
16. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis.
Maihöfner C; Probst-Cousin S; Bergmann M; Neuhuber W; Neundörfer B; Heuss D
Eur J Neurosci; 2003 Sep; 18(6):1527-34. PubMed ID: 14511332
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
20. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
